With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of ...

The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA ...

Nationally, 25% of patients admitted to the hospital from the emergency department have to wait 4 hours or more for a bed during nonpeak months.

COVID-19 mRNA-1283 vaccine was noninferior to the first-generation mRNA-1273 vaccine and elicited higher antibody responses against Omicron and D614G mutations.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

The 2025 World Bronchiectasis Conference highlighted new research on bronchiectasis and NTM - plus an emerging ...

The incidence of new-onset IA was higher after Lyme disease diagnosis vs influenza, especially during the first year postinfection.

The summer surge of COVID-19 continues with new federal data showing the virus is on the rise in many parts of the country.

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.

HealthDay News — Health officials in China are reporting more than 8,000 cases of chikungunya, a virus spread by mosquitoes that can cause fever and painful joints.

Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic ...